Search
I’m hoping that no one reading this has missed the launch of NAP7: perioperative cardiac arrest. The NAP7 data touched every part of anaesthesia practice – from maternity and neonates right through to the frail and older patient – so there’s something there for everyone.
But NAPs don’t stand still; NAP8 is on its way and will be looking at regional anaesthesia and neurological complications of anaesthesia. We are delighted that Professor Alan MacFarlane has been appointed to lead NAP8 – more news will be coming soon.
The work of CR&I is supported by a diverse group of clinical fellows (and this issue of the Bulletin even has a piece from a future research leader – aged 11). We couldn’t do our work without them, and they in turn are supported by their clinical workplaces – both in the NHS and the independent sector – who pay their salaries and give them the space to work with CR&I. I’m delighted that some of our fellows have given an insight into what the role is like – and the challenges of going and coming back from maternity leave.
The NIHR-HTA funded Continuous rectus sheath Analgesia in eMErgency LaparOTomy (CAMELOT) is another trial led by the Perioperative Medicine Clinical Trials Network (POMCTN) that is currently open for recruitment.
The study aims to find out whether adding rectus sheath catheters (RSCs) to standard analgesia provides better pain relief, fewer side effects and complications, and greater satisfaction for patients undergoing emergency laparotomy. It will also determine whether RSCs are safe and cost-effective. All POMCTN trials are registered with the NIHR Associate Principal Investigator (API) scheme. In this article, one of our trainees shares her experience working on the CAMELOT study.